<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04312451</url>
  </required_header>
  <id_info>
    <org_study_id>CLI ENDOVASC</org_study_id>
    <nct_id>NCT04312451</nct_id>
  </id_info>
  <brief_title>Prospective Cohort of Patients With Critical Limb Ischemia Undergoing Revascularization</brief_title>
  <acronym>CLI ENDOVASC</acronym>
  <official_title>Prospective Cohort of Patients With Critical Limb Ischemia Undergoing Revascularization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripheral Arterial Occlusive Disease is associated with a high risk of cardiovascular&#xD;
      events. The critical ischemia stage represents the most severe stage of Peripheral Arterial&#xD;
      Occlusive Disease, associated with decubitus pain and / or foot ulceration. The severity of&#xD;
      this arterial involvement involves functional prognosis of the lower limb with a high risk of&#xD;
      amputation, and the vital prognosis of the patient. In these patients, the rate of amputation&#xD;
      and mortality at 1 year can reach 20%. Therefore, the goal of management in a&#xD;
      multidisciplinary setting is limb salvage and improvement of the patient's vital prognosis.&#xD;
&#xD;
      In the vascular medicine department, the indication and modalities of the revascularization&#xD;
      procedure are discussed in a multidisciplinary consultation meeting. Surgical&#xD;
      revascularization by distal bypass requires venous material that can be used, a receiving&#xD;
      artery without diffuse lesions, in direct continuity with the arterial network of the foot,&#xD;
      and the absence of co-morbidities against general anesthesia. With the modernization and&#xD;
      development of endovascular equipment dedicated to the hamstrings, the interventional&#xD;
      radiology techniques in the management of critical ischemia allow the treatment of one or&#xD;
      more arterial axes as well as a very distal revascularization in the arteries. of the foot&#xD;
      with less morbidity-mortality compared to surgery, especially in patients the most fragile&#xD;
      patients. Since 2013, the endovascular revascularization procedures performed by the&#xD;
      interventional radiology team have been an integral part of the management of patients with&#xD;
      peripheral arterial disease of the lower limbs monitored in the vascular medicine department.&#xD;
      The hospital is therefore a privileged place to observe the long-term impact of this medical&#xD;
      care on the future of patients with different stages of severity of arterial disease.&#xD;
&#xD;
      The objective of this prospective study is to assess the vital prognosis, limb salvage and&#xD;
      associated prognostic factors in patients with critical ischemia supported by endovascular&#xD;
      revascularization in the vascular medicine service of the GHPSJ. The objective of this cohort&#xD;
      study is to build a database on critical ischemia in hospitalized patients, to judge the&#xD;
      management, monitoring and prognosis of patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 4, 2021</start_date>
  <completion_date type="Anticipated">January 25, 2027</completion_date>
  <primary_completion_date type="Anticipated">January 25, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Survival rate without major amputation</measure>
    <time_frame>Year 1</time_frame>
    <description>This outcome measure the survival rate without major amputation at 1 year.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of intraoperative deaths</measure>
    <time_frame>Day 1</time_frame>
    <description>This outcome measures the prevalence of intraoperative deaths.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of intraoperative cardiovascular events</measure>
    <time_frame>Day 1</time_frame>
    <description>This outcome measures the prevalence of intraoperative cardiovascular events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of intraoperative deaths, at 1 year</measure>
    <time_frame>Year 1</time_frame>
    <description>This outcome measures the prevalence of intraoperative deaths, at 1 year after the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of intraoperative cardiovascular events, at 1 year</measure>
    <time_frame>Year 1</time_frame>
    <description>This outcome measures the prevalence of intraoperative cardiovascular events at 1 year after the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healing rate</measure>
    <time_frame>Year 1</time_frame>
    <description>This outcome measures the healing rate, 1 year after the surgery.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Critical Limb Ischemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients are hospitalized in the vascular medicine department of the Paris Saint-Joseph&#xD;
        Hospital Group, for the management of critical ischemia of the lower limbs with decision to&#xD;
        revascularize by endovascular route for leg rescue, after discussion in multidisciplinary&#xD;
        staff (associating vascular physicians, vascular surgeons and interventional radiologists).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Man or Woman whose age is ≥ 18 years old&#xD;
&#xD;
          -  Patient with critical lower limb ischemia defined by the existence of decubitus pain&#xD;
             or a wound (foot ulcer or gangrene) evolving for more than 2 weeks associated with&#xD;
             hemodynamic criteria (systolic toe pressure &lt;30 mm Hg and / or systolic ankle pressure&#xD;
             &lt;50 mm Hg).&#xD;
&#xD;
          -  Hospitalized in the vascular medicine department&#xD;
&#xD;
          -  Endovascular revascularization gesture discussed and confirmed by multidisciplinary&#xD;
             staff&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under guardianship or curatorship&#xD;
&#xD;
          -  Patients deprived of their liberty&#xD;
&#xD;
          -  Patients objecting to the use of their data for this research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandra YANNOUTSOS, mD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Paris Saint Joseph</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandra YANNOUTSOS, MD</last_name>
    <phone>144123568</phone>
    <phone_ext>+33</phone_ext>
    <email>ayannoutsos@hpsj.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helene BEAUSSIER, PharmD, pHD</last_name>
    <phone>144127038</phone>
    <phone_ext>+33</phone_ext>
    <email>crc@hpsj.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Groupe Hospitalier Paris Saint-Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexandra YANNOUTSOS, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Helene BEAUSSIER, pharmD, pHD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Savji N, Rockman CB, Skolnick AH, Guo Y, Adelman MA, Riles T, Berger JS. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects. J Am Coll Cardiol. 2013 Apr 23;61(16):1736-43. doi: 10.1016/j.jacc.2013.01.054. Epub 2013 Apr 2.</citation>
    <PMID>23500290</PMID>
  </results_reference>
  <results_reference>
    <citation>Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015 Apr 24;116(9):1509-26. doi: 10.1161/CIRCRESAHA.116.303849. Review. Erratum in: Circ Res. 2015 Jun 19;117(1):e12.</citation>
    <PMID>25908725</PMID>
  </results_reference>
  <results_reference>
    <citation>Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 Jan;45 Suppl S:S5-67.</citation>
    <PMID>17223489</PMID>
  </results_reference>
  <results_reference>
    <citation>Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, Document Reviewers, Widimsky P, Kolh P, Agewall S, Bueno H, Coca A, De Borst GJ, Delgado V, Dick F, Erol C, Ferrini M, Kakkos S, Katus HA, Knuuti J, Lindholt J, Mattle H, Pieniazek P, Piepoli MF, Scheinert D, Sievert H, Simpson I, Sulzenko J, Tamargo J, Tokgozoglu L, Torbicki A, Tsakountakis N, Tuñón J, Vega de Ceniga M, Windecker S, Zamorano JL. Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368. doi: 10.1016/j.ejvs.2017.07.018. Epub 2017 Aug 26. Review.</citation>
    <PMID>28851596</PMID>
  </results_reference>
  <results_reference>
    <citation>Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008 May;47(5):975-981. doi: 10.1016/j.jvs.2008.01.005. Epub 2008 Apr 18.</citation>
    <PMID>18372148</PMID>
  </results_reference>
  <results_reference>
    <citation>Salas CA, Adam DJ, Papavassiliou VG, London NJ. Percutaneous transluminal angioplasty for critical limb ischaemia in octogenarians and nonagenarians. Eur J Vasc Endovasc Surg. 2004 Aug;28(2):142-5.</citation>
    <PMID>15234694</PMID>
  </results_reference>
  <results_reference>
    <citation>Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Dalla Paola L, Mariani G, Poli M, Settembrini PG, Sciangula L, Morabito A, Graziani L. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med. 2002 Sep;252(3):225-32.</citation>
    <PMID>12270002</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 16, 2020</study_first_submitted>
  <study_first_submitted_qc>March 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

